Skip to main content

Day: March 17, 2022

L’Oréal: News Release: “Annual General Meeting to be held on Thursday 21 April 2022 / 2021 Universal Registration Document”

  NEWS RELEASE Clichy, 17 March 2022                     Annual General Meeting to be held on Thursday 21 April 2022 / 2021 Universal Registration Document.     Clichy, 17 March 2022 – L’Oréal, the world’s leading beauty company, announced terms of information availability regarding the Annual General Meeting to be held on Thursday 21 April 2022 and the 2021 Universal Registration Document.   TERMS OF INFORMATION AVAILABILITY REGARDING THE ANNUAL GENERAL MEETING OF THURSDAY 21 APRIL 2022  The Annual General Meeting of L’Oréal (hereafter the “Company”) will be held on Thursday 21 April 2022 at 10 a.m.(Paris time) at Le Palais des Congrès de Paris (2, place de la Porte Maillot, 75017 Paris). Shareholders of the Company who wish to physically attend the General Meeting would have to comply with the health measures in force at the time of...

Continue reading

Strong FY2021 performance driven by Believe’s attractivity to artists and labels demonstrating the strength of its digital platform model

Strong FY2021 performance driven by Believe’s attractivity to artists and labels demonstrating the strength of its digital platform model Group’s revenue growth: +30.7% with organic growth at +29.9% Digital revenue growth: +33.6% reflecting solid market share gains Adjusted EBITDA margin of 4%, up 230bps resulting from the business growth Paris, March 17, 2021 – Believe (Ticker: BLV, ISIN: FR0014003FE9), one of the world’s leading global digital music companies, published today its FY 2021 sales and earnings.   Denis Ladegaillerie, Founder and CEO, said: “In 2021, Believe has once again demonstrated its capacity to deliver strong and profitable growth while continuing to invest for the future. We are very proud to have attracted and supported the development of a record number of amazing independent artists and labels around the world...

Continue reading

LUMIBIRD 2021 EARNINGS: INITIAL TARGET ACHIEVED FOR AN EBITDA/REVENUE RATIO OF OVER 20%

Lannion, March 17, 2022 – 5:45pm 2021 EARNINGS: INITIAL TARGET ACHIEVED FOR AN EBITDA/REVENUE RATIO OF OVER 20%EBITDA up 25% proforma to €32.6m (20.1% of revenues) Continued increase in profitability for the Medical division, driven by the successful integration of Ellex Financial position adapted to the growth strategyThe LUMIBIRD Group, the European leader for laser technologies, achieved an EBITDA/revenue ratio of 20.1% in 2021, within the target range of 20% to 25%. This performance was supported by double-digit organic growth and an increase in the gross margin rate, particularly for the Medical division. After achieving this first target, LUMIBIRD is confirming its strategic objectives to double its reported revenues between 2020 and 2023, driven by organic and external growth, while increasing its EBITDA/revenue ratio within...

Continue reading

PURA and PAOG To Launch CBD Product Line Next Month For $40 Billion Women’s Health Market

Dallas, Texas, March 17, 2022 (GLOBE NEWSWIRE) — Puration, Inc. (OTC Pink: PURA) and PAO Group, Inc. (OTC Pink: PAOG) are working together on a new line of CBD Nutraceuticals under PURA’s Farmersville Hemp Brand Name for the $40 billion women’s health market. PURA and PAOG anticipate the new Farmersville Brand CBD Nutraceutical Line to boost 2022 revenue potentially beyond current projections. PAOG revealed in a February strategic update that the two companies were working together on a new line of CBD Nutraceuticals under PURA’s Farmersville Hemp Brand Name.  The joint CBD Nutraceutical developments have progressed, and the two companies now plan to launch the new product line next month in April. The new CBD Nutraceuticals will be available on North American Cannabis Holding, Inc.’s (OTC Pink: USMJ) ecommerce site www.USMJ.com. Look...

Continue reading

Biofrontera to Showcase Actinic Keratoses and Impetigo Treatments at the 2022 American Academy of Dermatology Annual Meeting

Company to have a strong onsite presence at the world’s largest scientific conference for dermatologists, with approximately 10,000 medical professionals expected to attend WOBURN, Mass., March 17, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatologic products, announced today it will be hosting a booth showcasing its innovative, FDA-approved products at the 2022 American Academy of Dermatology (AAD) Annual Meeting taking place March 25-29, 2022 at the Boston Convention and Exhibition Center. “We look forward to a strong presence at the year’s largest and most prestigious dermatology conference following encouraging momentum with our clinical studies and our commercial footprint. We anticipate a busy booth and look forward to connecting with dermatologists,...

Continue reading

Constitutive meeting of Lassila & Tikanoja Plc’s Board of Directors

Lassila & Tikanoja plc Stock exchange release 17 March 2022 at 5:05 pm Constitutive meeting of Lassila & Tikanoja Plc’s Board of Directors At its constitutive meeting on 17 March 2022, the Board of Directors of Lassila & Tikanoja plc elected Jukka Leinonen as Chairman of the Board and Sakari Lassila as Vice Chairman. From among its members, the Board elected Sakari Lassila as the Chairman of the Audit Committee and Teemu Kangas-Kärki and Laura Lares as the members of the committee. The Board elected Jukka Leinonen as the Chairman of the Personnel and Sustainability Committee, with Laura Tarkka and Pasi Tolppanen as the members of the committee. LASSILA & TIKANOJA PLC Eero Hautaniemi President and CEO For additional information, please contact: Sirpa Huopalainen General Counsel tel. +358 40 596 5241 Lassila & Tikanoja...

Continue reading

Information regarding Coop Pank AS application for obtaining an additional license for issuing covered bonds

Coop Pank AS (the bank) announces that the bank has withdrawn the application submitted by the bank for additional activity licenses for the issuance of covered bonds. On 30 November 2021, the bank submitted an application to the Financial Supervision Authority for an additional activity license allowing the issuance of covered bonds. Following the application, the macroeconomic context in Estonia and throughout Europe has changed significantly. In today’s environment, it is not possible for the bank to predict the essential conditions for the possible future issuance of covered bonds. Therefore, the bank does not currently consider it possible to proceed with the procedure of the additional activity license required for the issuance of covered bonds and has decided to withdraw the respective application from the Financial Supervision...

Continue reading

Atos ensures effective and secure delivery of the Olympic and Paralympic Winter Games Beijing 2022

World-record for Winter Games with over 64 million people using the result webpage in the Olympic official website and app Beijing, China, and Paris, France – March 17, 2022 – The Olympic and Paralympic Winter Games Beijing 2022 ended after a successful edition, despite the unique context in which the event was held. These games saw more than 3,400 athletes compete, supported by key digital systems which were orchestrated and secured by Atos, leveraging its global digital platforms, infrastructure, and cloud orchestration expertise. For 30 years, Atos has been supporting the Olympic and Paralympic Games, driving digital innovation so all sports fans can experience the athletes’ achievements in real-time from anywhere, and on any device. No rest for the brave: Atos teams have already started to work on the preparation of the Olympic...

Continue reading

IQST – iQSTEL Initiates Nasdaq Application Process On Schedule

New York, NY, March 17, 2022 (GLOBE NEWSWIRE) — iQSTEL, Inc. (OTCQX: IQST) today released an update highlighting the company’s latest progress toward its 2022 objectives to include reaching a $90 million revenue forecast and uplisting to Nasdaq in the first half of this year. The shareholder updates from CEO Leandro Iglesias are included in their entirety below. Dear Shareholders: Leading news headlines continue to impact investor sentiment and weigh on the overall market.  There is no need for me to review the news here.  We all get enough of it elsewhere. In spite of all the prevailing headlines, iQSTEL is proceeding in 2022 as planned.  We remain on course to achieve our $90 million annual revenue projection and realize our planned uplisting to Nasdaq within the first half of this year.  We are optimistic the global events currently...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.